Early Promise: Phase 2 Trials Showing ~20% Mean Weight Loss Phase 2 trials for Retatrutide have shown incredibly promising results
TB-500 is commonly discussed as a synthetic fragment related to thymosin beta-4, a naturally occurring peptide involved in cell migration, actin regulation, and wound-healing biology
Mir Ali, MD, board certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who was not involved in the study, said: As far as I know, no definite mechanism to link GLP-1 medications and suicidal ideation [has been described]. He also said, There is disagreement because the incidence [of suicidal ideation] is so rare that it is difficult to accurately assess and try to delineate a possible reason for this. Separating existing psychological stressors from those possibly caused by GLP-1 is also difficult
Acute pancreatitis presents as severe upper abdominal pain radiating to the back, often with nausea/vomiting that is qualitatively different from titration-related GI events
Remember, the most substantial weight loss and metabolic improvements are usually seen after several months of consistent, guided use
Patients should verify their specific weight loss medication and treatment coverage, including prior authorization requirements, with UnitedHealthcare before beginning care